Cubist(CBST) is up 5% today on heavy volume of 1.2M shares on no apparent news.52 week high is $25.48.On Monday the stock was $21.5.
Maybe there is news on the TEVA lawsuit. CBST has a compelling valuation with ~$900M in cash and forecasted revenues of $688M, EPS of 34c/sh. with a market cap of $1.45B .
It is one of Jeffries’ Top Picks in healthcare with a target of $29.
Cubist Pharmaceuticals: Lots of Cash and Low Valuation – Seeking Alpha
Other upside big movers in the Model Portfolio are:
Regeneron(REGN $39.93) up 3%, Supergen(SUPG $2.90) up 4%, Viropharma (VPHM $19.38) up 7.8%.
Value and acquisition play Cephalon(CEPH $57.65) is up 0.8%.